Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Differential effects of FR900482 and FK317 on apoptosis, IL-2 gene expression, and induction of vascular leak syndrome.

Beckerbauer L, Tepe JJ, Eastman RA, Mixter PF, Williams RM, Reeves R.

Chem Biol. 2002 Apr;9(4):427-41.

2.

FR900482 class of anti-tumor drugs cross-links oncoprotein HMG I/Y to DNA in vivo.

Beckerbauer L, Tepe JJ, Cullison J, Reeves R, Williams RM.

Chem Biol. 2000 Oct;7(10):805-12.

3.

FK317: a novel substituted dihydrobenzoxazine with potent antitumor activity which does not induce vascular leak syndrome.

Naoe Y, Inami M, Matsumoto S, Nishigaki F, Tsujimoto S, Kawamura I, Miyayasu K, Manda T, Shimomura K.

Cancer Chemother Pharmacol. 1998;42(1):31-6.

PMID:
9619755
4.

Activation of intrinsic and extrinsic proapoptotic signaling pathways in interleukin-18-mediated human cardiac endothelial cell death.

Chandrasekar B, Vemula K, Surabhi RM, Li-Weber M, Owen-Schaub LB, Jensen LE, Mummidi S.

J Biol Chem. 2004 May 7;279(19):20221-33. Epub 2004 Feb 11.

5.
6.

Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.

Hamaï A, Richon C, Meslin F, Faure F, Kauffmann A, Lecluse Y, Jalil A, Larue L, Avril MF, Chouaib S, Mehrpour M.

Oncogene. 2006 Dec 7;25(58):7618-34. Epub 2006 Sep 18. Erratum in: Oncogene. 2007 Feb 22;26(8):1256.

PMID:
16983347
7.
8.

Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas.

Herr I, Ucur E, Herzer K, Okouoyo S, Ridder R, Krammer PH, von Knebel Doeberitz M, Debatin KM.

Cancer Res. 2003 Jun 15;63(12):3112-20.

9.

Induction of apoptosis and/or necrosis following exposure to antitumour agents in a melanoma cell line, probably through modulation of Bcl-2 family proteins.

Shibuya H, Kato Y, Saito M, Isobe T, Tsuboi R, Koga M, Toyota H, Mizuguchi J.

Melanoma Res. 2003 Oct;13(5):457-64.

PMID:
14512787
10.

Influence of hypoxia on TRAIL-induced apoptosis in tumor cells.

Weinmann M, Marini P, Jendrossek V, Betsch A, Goecke B, Budach W, Belka C.

Int J Radiat Oncol Biol Phys. 2004 Feb 1;58(2):386-96.

PMID:
14751507
12.

DNA damaging drugs-induced down-regulation of Bcl-2 is essential for induction of apoptosis in high-risk HPV-positive HEp-2 and KB cells.

Singh S, Chhipa RR, Vijayakumar MV, Bhat MK.

Cancer Lett. 2006 May 18;236(2):213-21. Epub 2005 Jul 5.

PMID:
15996812
13.

The alkylphospholipid perifosine induces apoptosis of human lung cancer cells requiring inhibition of Akt and activation of the extrinsic apoptotic pathway.

Elrod HA, Lin YD, Yue P, Wang X, Lonial S, Khuri FR, Sun SY.

Mol Cancer Ther. 2007 Jul;6(7):2029-38. Epub 2007 Jun 29.

14.

Physiological and molecular effects of Apo2L/TRAIL and cisplatin in ovarian carcinoma cell lines.

Siervo-Sassi RR, Marrangoni AM, Feng X, Naoumova N, Winans M, Edwards RP, Lokshin A.

Cancer Lett. 2003 Feb 10;190(1):61-72.

PMID:
12536078
15.

Constitutive expression of IL-2Rbeta chain and its effects on IL-2-induced vascular leak syndrome.

Assier E, Jullien V, Lefort J, Moreau JL, Vargaftig BB, Lapa e Silva JR, Thèze J.

Cytokine. 2005 Dec 21;32(6):280-6. Epub 2005 Dec 27.

PMID:
16378732
16.

Role of death receptor and mitochondrial pathways in conventional chemotherapy drug induction of apoptosis.

Wang P, Song JH, Song DK, Zhang J, Hao C.

Cell Signal. 2006 Sep;18(9):1528-35. Epub 2006 Jan 25.

PMID:
16442262
17.

Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4.

Todaro M, Lombardo Y, Francipane MG, Alea MP, Cammareri P, Iovino F, Di Stefano AB, Di Bernardo C, Agrusa A, Condorelli G, Walczak H, Stassi G.

Cell Death Differ. 2008 Apr;15(4):762-72. doi: 10.1038/sj.cdd.4402305. Epub 2008 Jan 18.

18.

IL-4 protects tumor cells from anti-CD95 and chemotherapeutic agents via up-regulation of antiapoptotic proteins.

Conticello C, Pedini F, Zeuner A, Patti M, Zerilli M, Stassi G, Messina A, Peschle C, De Maria R.

J Immunol. 2004 May 1;172(9):5467-77.

Supplemental Content

Support Center